These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 31431138)

  • 1. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
    Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
    Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and patient satisfaction of single-session transoral incisionless fundoplication and laparoscopic hernia repair.
    Gisi C; Wang K; Khan F; Reicher S; Hou L; Fuller C; Sattler J; Eysselein V
    Surg Endosc; 2021 Feb; 35(2):921-927. PubMed ID: 32691205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Interdisciplinary Approach to GERD: Concomitant Laparoscopic Hiatal Hernia Repair with Transoral Incisionless Fundoplication.
    Choi AY; Roccato MK; Samarasena JB; Kolb JM; Lee DP; Lee RH; Daly S; Hinojosa MW; Smith BR; Nguyen NT; Chang KJ
    J Am Coll Surg; 2021 Mar; 232(3):309-318. PubMed ID: 33346082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.
    Bell RC; Freeman KD
    Surg Endosc; 2011 Jun; 25(6):1975-84. PubMed ID: 21140170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease.
    Ihde GM; Besancon K; Deljkich E
    Am J Surg; 2011 Dec; 202(6):740-6; discussion 746-7. PubMed ID: 22014853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH Scores in Hiatal Repair with Transoral Incisionless Fundoplication.
    Ihde GM; Pena C; Scitern C; Brewer S
    JSLS; 2019; 23(1):. PubMed ID: 30675094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
    Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
    World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant hiatal hernia repair with transoral incisionless fundoplication for the treatment of refractory gastroesophageal reflux disease: a systematic review.
    Jaber F; Ayyad M; Ayoub F; Patel KK; Makris KI; Hernaez R; Skef W
    Surg Endosc; 2024 Oct; 38(10):5528-5540. PubMed ID: 39271515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms.
    Trad KS; Turgeon DG; Deljkich E
    Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication.
    Ghosh G; Choi AY; Dbouk M; Greenberg J; Zarnegar R; Murray M; Janu P; Thosani N; Dayyeh BKA; Diehl D; Nguyen NT; Chang KJ; Canto MI; Sharaiha R;
    Surg Endosc; 2023 May; 37(5):3701-3709. PubMed ID: 36650353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
    Testoni PA; Vailati C; Testoni S; Corsetti M
    Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of Laryngopharyngeal Symptoms to Transoral Incisionless Fundoplication in Patients with Refractory Proven Gastroesophageal Reflux.
    Snow GE; Dbouk M; Akst LM; Ihde G; Zarnegar R; Janu P; Murray M; Eskarous H; Sohagia A; Dhar SI; Irene Canto M
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):662-670. PubMed ID: 34378427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic Hiatal Hernia Repair With Concomitant Transoral Incisionless Fundoplication.
    Pype DL
    AORN J; 2023 Mar; 117(3):149-158. PubMed ID: 36825913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
    Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
    Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between gastroesophageal junction integrity and symptomatic fundoplication outcomes.
    Turner B; Helm M; Hetzel E; Schumm M; Gould JC
    Surg Endosc; 2020 Mar; 34(3):1387-1392. PubMed ID: 31214803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.
    Cadière GB; Van Sante N; Graves JE; Gawlicka AK; Rajan A
    Surg Endosc; 2009 May; 23(5):957-64. PubMed ID: 19288158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.
    Chimukangara M; Jalilvand AD; Melvin WS; Perry KA
    Surg Endosc; 2019 Apr; 33(4):1304-1309. PubMed ID: 30167944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.